Thursday, March 28, 2024
Homebiotech and pharmaceuticalsAlnylam CEO backs inflation-based drug price hikes, welcomes Amazon's foray into health...

Alnylam CEO backs inflation-based drug price hikes, welcomes Amazon’s foray into health care

  • Before the approval of Alnylam's first drug, CEO John Maraganore backed the idea of raising prices pegged to inflation.
  • Maraganore also said he welcomes a conversation with Amazon to disrupt drug distribution.

RELATED ARTICLES
- Advertisment -

Most Popular